Episode Details

Show from 4/17/20 Wharton Finance Professor Jeremy Siegel kicks off the show with a market update and discusses the news about Remdesivir, an antiviral medicine made by Gilead Sciences. Professor Siegel says a therapeutic is most important at this time so that the economy can start up again. Then, Penn Medicine's Dr. Ronald Barg joins the show to explain the impact of COVID-19 on hospitals and the research being done to contain the virus. Dr. Barg said there is still very little known, they don't understand why people who seem to be doing well become worse. Guest: Ronald Barg, MD - Physician Executive, Penn Primary Care at Penn Medicine For more on him visit his physician page: https://www.pennmedicine.org/providers/profile/ronald-barg